Emcure Pharmaceuticals Limited (BOM: 544210)

Market Cap	263.02B
Revenue (ttm)	72.56B
Net Income (ttm)	5.67B
Shares Out	n/a
EPS (ttm)	31.02
PE Ratio	46.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	520
Average Volume	3,583
Open	1,334.80
Previous Close	1,361.35
Day's Range	1,334.80 - 1,391.00
52-Week Range	1,226.50 - 1,577.50
Beta	n/a
RSI	48.87
Earnings Date	Feb 6, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 10,852
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544210

Financial Performance

In 2023, Emcure Pharmaceuticals's revenue was 66.58 billion, an increase of 11.23% compared to the previous year's 59.86 billion. Earnings were 4.98 billion, a decrease of -6.36%.